Bee venom
Introduction
The bee venom (BV) produced by Africanized honey bee-AHB (Apis mellifera L.) is a complex mixture of enzymes, lipids, amino acids, carbohydrates and peptides like apamin and melittin. It also contains dopamine and phospholipase A 2 (Hider, 1988; Sciani et al., 2010; Ferreira-Junior et al., 2010) . Melittin constitutes 40 to 60% of dry whole honeybee venom, and this peptide has various biological activities, including high anti-inflammatory activity (Habermann, 1972; Gauldie et al., 1976; Son et al., 2007) .
Experimental studies have shown neuroprotective effects of BV and melittin in amyotrophic lateral sclerosis (Yang et al., 2010; and 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine (MPTP) model of Parkinson's disease in vivo (Doo et al., 2010; Kim et al., 2011a; Chung et al., 2012; Doo et al., 2012; Cho et al., 2012) and against glutamatergic excitotoxicity in neuronal and glial cell cultures . Effectiveness of BV acupuncture was also demonstrated for idiopathic Parkinson's disease (Cho et al., 2012) .
The subcutaneous administration of BV has also been shown to induce the activation of catecholaminergic neurons in the arcuate nucleus in the hypothalamus of rats and in dopaminergic nuclei, including the nucleus accumbens, substantia nigra, and locus coeruleus. When combined with acupuncture, it was able to reduce methamphetamine-induced hyperactivity (Kim et al., 2011b) . In addition, it has been shown that BV exhibited no signs of toxicity when administered within a therapeutic range subcutaneously (s.c.) (Kim et al., 2004) .
Despite the wide range of proposed uses for BV and melittin, the pharmacological effects in the central nervous system that result from their administration under physiological conditions have been poorly addressed. The development of new therapeutic approaches to mental disorders and neurodegenerative diseases remains a challenge. So, this study aimed to examine the pharmacological effects of BV and melittin in mice, with particular emphasis on dopaminergic related behaviors.
Materials and methods

Animals and ethical statements
Male Swiss albino mice (25-30 g) were maintained in a temperature and light cycle-controlled environment with free access to water and food. All procedures were in accordance with the standards of the Brazilian College of Animal Experimentation, and the experimental protocol was approved by the Ethical Committee for Animal Use of the Tiradentes University, Aracaju-SE, Brazil (approval number 010213).
Drugs
The bee venom (BV) was purchased from an apiary in the city of São Roque-SP, in the Brazilian Southeast region, it was obtained by electric extraction. Other commercial chemicals were used: melittin (Sigma ® , São Paulo, Brazil), haloperidol (Janssen-Cilag Pharmaceuticals ® Ltda, São Paulo, Brazil), Imipramine hydrochloride (Novartis Biosciences ® S.A., São Paulo, Brazil) and diazepam (Union SA National Pharmaceutical Chemistry ® , São Paulo, Brazil).
Assays
Pharmacological evaluation of the acute effects
The animals received vehicle, melittin (0.1 mg/kg) or BV (0.1 mg/kg or 1.2 mg/kg). Both BV and melittin were diluted in saline [0.9%, 40 µl], administered subcutaneously (s.c.); the doses were chosen based on previous articles (Doo et al., 2010; Kim et al., 2011abc; Lee et al., 2001; Yang et al., 2010; . Behavioral tests were performed 30 min after the treatments. The data were compared with the obtained after treatment with the antipsychotic haloperidol [0.2 mg/kg, intraperitoneal (i.p.)], imipramine (10 mg/kg. i.p.) and diazepam (1 mg/kg. i.p.). In the groups that received haloperidol and BV, haloperidol was injected 30 min prior the BV.
Catalepsy test
Catalepsy, defined as failure to correct an externally imposed posture, was evaluated according to the standard horizontal bar hanging test by placing the animals with both forelegs over a horizontal glass bar with 0.5 cm diameter, and 4.5 cm high from the ground (Sanberg et al., 1988) . The time during which the mouse maintained this position was recorded for up to 300 s, with three tries allowed to replace the animal in the cataleptic position. Catalepsy was considered to have ended when the forepaw touched the floor or when the mouse climbed the bar (Del Bel et al., 2010) .
The open-field test
To evaluate the motor and emotional state, an open-field test was performed (Whimbey and Denenberg, 1967; Prut and Belzung, 2003) . The following parameters were evaluated for 5 min: locomotion or crossings (number of line crosses), rearings (the number of times the mouse stands on its hind legs), grooming (the number of times the mouse "washes" itself by licking during the observation period) and time spent in the central area. The equipment was made of white colored wood, and it consisted of a quadrilateral with a rectangular area of 4830.25 cm 2 and walls 34.5 cm high, with the base subdivided into sixteen quadrants (Hongxing et al., 2007; O'Leary et al., 2013) .
Apomorphine-induced stereotipy
The apomorphine-induced stereotypies were measured by a score scale (from 0 to 6 where 0 = asleep or stationary; 1 = active; 2 = predominantly active but with bursts of stereotyped sniffing and rearing; 3 = constant stereotyped activity such as sniffing, rearing or head bobbing, but with locomotor activity still present; 4 = constant stereotyped activity maintained in one location; 5 = constant stereotyped activity but with bursts of licking and/or gnawing and biting; and 6 = continual licking and or gnawing of cage grids) after the application of apomorphine (20 mg/kg, s.c., Sigma-Aldrich Brasil Ltda., São Paulo, Brazil). Each animal was observed for 10 s intervals every 10 min for 60 min (Setler et al., 1976) . The results were expressed as the mean sum of scores that were obtained for each group.
The elevated plus-maze test
To evaluate possible action on anxiety, the elevated plusmaze was used. The number of entries and the stay duration of the animals in the open and closed arms (Pellow et al., 1985) were analyzed in an apparatus with a base 45 cm (height) from the ground, with two open arms (50 × 10 cm) and two enclosed arms of the same size, with walls 40 cm in height uncovered on the top. Each mouse was observed for 5 min.
The forced swimming test
The forced swimming test was carried out as previously described (Porsolt et al., 1977) in order to evaluate a possible antidepressant effect. The test consisted of two swim sessions separated by a period of 24 h. In the first session, the animals were placed in a circular water tank (30 cm high) for 15 min. After a period of intense movement, the animals acquire a posture of immobility, with minimal movements to keep the head out of the water. In the second session (test), the animals underwent the same procedure for 5 min. the swimming and immobility times were evaluated.
Statistical analysis
After applying the Kolmogorov-Smirnov normality test, the gaussian data (mean ± standard error of the mean) of the catalepsy, open-field, elevated plus-maze and forced swimming tests were subjected to a one-way analysis of variance (ANOVA) followed by a Tukey post hoc test. Non Gaussian data (scores) from apomorphine-induced stereotypy were analyzed by Kruskal-Wallis test followed by a Dunn's multiple comparison test. All statistical analysis was performed using SPSS Statistics 19.0 software. Values of p < 0.05 were considered statistically significant.
Results
Pharmacological evaluation of the acute effects
Cataleptic effect
The statistical analysis of catalepsy revealed a significant difference between treatments (F 5-59 = 8.086, p < 0.0001; ANOVA followed by Tukey post-test), as illustrated in Table 1 . The groups treated with 0.1 mg/kg of BV and melittin (0.1 mg/kg) recorded lesser time spent on the bar. In contrast, the administration of 1.2 mg/kg of BV induced cataleptic activity, an effect similar to that observed with haloperidol treatment. When the treatments were combined, it was observed that a lower dose of BV did not modify the action of haloperidol, while the administration of 1.2 mg/kg reversed the observed effects. The animals that received saline solution did not remain on the bar and thus were not subject to statistical analysis.
Group
Treatment n Dose (mg/kg) Catalepsy (s) The results are expressed as mean ± standard error of the mean (SEM). a p < 0.05 from groups 2; 3 and 7. b p < 0.01 from groups 2; 3 and 7 [one-way analysis of variance (ANOVA) followed by Tukey post-test]. BV, bee venom, n, number of animals per group. The animals that receive saline solution did not remain on the bar and thus no statistical analysis was performed. 
Locomotor and exploratory activity
In the open-field test, the administration of BV at a dose of 1.2 mg/kg caused a significant reduction in the number of crossings compared to the other treatments. The same result was observed after the administration of haloperidol. This effect was not observed when the treatments were associated (Table 2, ANOVA followed by Tukey post-test, F 6-34 = 14.122, p < 0.0001). When rearing was examined, both doses of bee venom and treatment with haloperidol resulted in a significant reduction compared to that seen in controls (F 6-34 = 8.687, p < 0.0001, ANOVA followed by Tukey post-test). The reduction remained significant when the lowest dose of BV was preceded by haloperidol, but the effect was reversed in the group receiving 1.2 mg/kg of BV (Table 2 ). In addition, there was a significant decrease in grooming behavior after 1.2 mg/kg of BV compared to the saline group (F 6-34 = 3.525, p = 0.010, ANOVA, followed by Tukey post-test).
Neuroleptic effect
Both doses of BV and melittin decreased apomorphine-induced stereotypies (p = 0.006, Kruskal-Wallis test followed by Dunn's multiple comparison test). However, there were no dosedependent effects (p = 0.82). The results are shown in the Figure 1 . 
Discussion
The results of this study showed that BV induced catalepsy in rodents, decreased apomorphine-induced stereotypies, and changed the parameters associated with motor activity in the open-field test. These effects were similar to the actions that described for the neuroleptic haloperidol, and a significant interaction was found when the bee venom treatment was combined with haloperidol. The haloperidol-induced catalepsy is characterized by the occupation of striatal dopamine receptors (Sanberg, 1980) . The finding of a cataleptic effect reduction associated to the treatments might suggest the occupation of these receptors by BV, and a competitive interaction of BV with haloperidol. The components that are present in BV have been related to dopaminergic transmission. Studies revealed that melittin decreases the uptake of dopamine by acting directly on the dopamine transporter, and inhibits the binding of D2 receptors with antagonist in cell culture (Keith et al., 2011; . The other bioactive compound in BV, apamin, acts as a blocker of 
Anxiolytic effect
Regarding to the elevated plus-maze, the acute treatment with bee venom and melittin did not result in a significant effect on the assessment of anxiolytic activity. No changes were observed on the time spent in the open arms between the groups (F 4-31 = 2.196, p = 0.096). Only the administration of diazepam significantly increased the number of entries into the open arms (F 4-31 = 3.598, p = 0.018, one way ANOVA followed by Tukey post-test, Figure 2 ).
Antidepressant effect
Both doses of BV induced a significant increase in the immobility time observed in the forced swimming test, compared to imipramine (F 4-30 = 3.219, p = 0.028, one way ANOVA followed by Tukey post-test, Table 3 ). From saline group, BV induced about 70% increase in the immobility time, and melittin induced about 20%, although these differences were not found statically relevant. potassium channels and may cause an increased activity of dopaminergic neurons through D2 receptors (Vandecasteele et al., 2011) . The microinjection of apamin in the nucleus accumbens of rats has been shown to produce increased motor activity and augmented brain levels of dopamine and its metabolites (Steketee and Kalivas, 1990) . The behavioral effects were distinct to those observed in the open-field test in this study, nevertheless, it is noteworthy that the authors also observed a reversal by pre-treatment with haloperidol. Those findings are consistent with this study's results that revealed that the administration of bee venom and haloperidol resulted in the reversal of the cataleptic effects, indicating that the active ingredients of bee venom may mediate the catalepsy that could be induced by D2 receptor occupancy.
Since the modifications in the spontaneous motor activity may be mediated by D2 receptors (Zuo et al., 2008) while D1 receptors are involved in grooming (Drago et al., 1999) , the results point to an interaction of BV with the dopaminergic system. In agreement with this hypothesis, we observed a reduction in stereotypies induced by apomorphine after acute bee venom and melittin treatment. The stereotypy results from apomorphine interactions with dopamine receptors (Randrup and Munkvad, 1974) and it is a test frequently used for evaluating the properties of antipsychotic drugs.
To date, previous studies in the literature have investigated the effects of BV on behaviors related to pain and inflammation (Roh et al., 2006; Merlo et al., 2011) , the prevention of amphetamine addiction (Kwon et al., 2010) , and neuroprotective effects against neuronal death (Kim et al, 2011a) . One study conducted (Kim et al., 2004) with lower doses reported no effects of the BV and its sub-fractions on sleep-induction time and duration, motor function in mice (rota-rod test), general spontaneous activity and pentyleneteterazole-induced convulsions in mice. An antipsychotic activity would be, therefore, a novel therapeutic effect of BV if lower doses are tested and proved efficient.
More experiments with selective antagonists of different dopamine receptors are needed to elucidate the mechanism of action of the BV and melittin, but it is important to note that melittin displayed action on the apomorphine-induced stereotypies without side effects on motor performance or catalepsy with the dose tested. Neither BV nor melittin promoted depressant effect as assessed by the forced swimming test. It has been well demonstrated that drugs with antidepressant activity reduce the time during the animals remained immobile (Borsini and Meli, 1988) . Thus, the results indicate a neuroleptic-like but not antidepressant effect for BV.
In addition, there was no effect of the BV and melittin on the anxiety parameters assessed by the elevated plus-maze test. It can indicate an absence of interaction with GABAergic system. Diazepam has been employed in behavioral pharmacology as a reference compound for potential anxiolytic-like substances (Mizushige et al., 2013) . Here, it increased the number of entries in the open arms as expected. Although diazepam promoted an increase about 30% on the percent of the time spent in the open arms from the saline group, the statistical analysis failed to reveal a significant effect. This may be due the high SEM in the control groups and/or the reduced number of animals in some groups (n = 5-9).
